Seed Round - Codagenix
Investment Firm
Overview
Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.
Announced Date
Dec 16, 2014
Funding Type
Seed
Highlights
Location
New York, United States, North America
Social
Participant Investors
1
| Investor Name |
|---|
 Accelerate Long Island |
Round Details and Background
Codagenix raised $100000 on 2014-12-16 in Seed Round
Codagenix develops live-attenuated viral vaccines to provide target antigens placed in an attenuated backbone virus.
Company Funding History
12
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Oct 12, 2017 |  Venture Round - Codagenix | 1 | - | 3.0M |
| Jun 12, 2015 | Series A - Codagenix | 1 | - | 2.0M |
| Jun 28, 2014 | Grant - Codagenix | - | 1.2M | |
| Jul 01, 2012 | Grant - Codagenix | - | 600.0K |
Recent Activity
There is no recent news or activity for this profile.